Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial By Guilherme GuainJune 30, 2022
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study By Guilherme GuainJune 30, 2022
Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial By Guilherme GuainJune 30, 2022
A Double-blind, Placebo-controlled Study Of The Omega-3 Fatty Acid Docosahexaenoic Acid In The Treatment Of Major Depression By Guilherme GuainJune 30, 2022
Addition Of Omega-3 Fatty Acid To Maintenance Medication Treatment For Recurrent Unipolar Depressive Disorder By Guilherme GuainJune 30, 2022
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study By Guilherme GuainJune 30, 2022
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder By Guilherme GuainJune 30, 2022
Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing By Guilherme GuainJune 30, 2022
Omega-3 fatty acids for a better mental state in working populations – Happy Nurse Project: A 52-week randomized controlled trial By Guilherme GuainJune 30, 2022
Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: “a pilot trial” By Guilherme GuainJune 30, 2022